Research and Development

Showing 15 posts of 9058 posts found.

BioNTech and CEPI partner for development of mRNA mpox vaccine

September 19, 2023 Research and Development BioNTech, CEPI, Immunology, mpox

BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advance the development of mRNA-based vaccine …

BMS shares new research and development  plans at the company’s R&D day

September 15, 2023 Research and Development BMS, Pharmacy, R&D, development, research

Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, US, in order to discuss …

Nuvectis Pharma initiates phase 1a NXP900 clinical trial

September 13, 2023 Research and Development Cancer, Nuvectis Pharma, Oncology, clinical trial

Clinical stage biopharmaceutical company Nuvectis Pharma has announced the initiation of a phase 1a dose escalation clinical study of NXP900, …

NHS-integrated pharmacy app Charac receives £1.2m funding

September 12, 2023 Research and Development Charac, Pharmacy, app, digital health, pharmacies

Charac, an NHS-integrated pharmacy app, has raised £1.2m in debt and equity financing from the National Pharmacy Association (NPA) and …

Neurocrine Biosciences begins phase 1 study assessing NBI-1117570 in healthy adults

September 12, 2023 Research and Development Neurocrine Biosciences, Neurology, Sosei Heptares, clinical trial

Sosei Heptares has announced that its partner, Neurocrine Biosciences, has initiated its phase 1 first-in-human clinical trial to assess the …

Sandoz announces deal to commercialise biosimilar ustekinumab in Europe and North America

September 11, 2023 Research and Development Pharmacy, SB17, Sandoz, commercialisation, ustekinumab

Sandoz has announced that it has entered into a development and commercialisation agreement with Samsung Bioepis, providing Sandoz the exclusive …

CymaBay shares results from phase 3 RESPONSE trial for seladelpar

September 8, 2023 Research and Development CymaBay, PBC, Pharmacy, clinical trial, seladelpar

CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …

Vaxart shares topline data from phase 2 study of norovirus vaccine candidate

September 8, 2023 Research and Development Infections and infestations, Vaccine, Vaxart, norovirus

Vaxart has announced topline data from its phase 2 challenge study which assessed its oral tablet monovalent norovirus vaccine candidate. …

BridgeBio Pharma shares positive feedback from FDA and EMA for phase 3 trial of infigratinib

September 7, 2023 Research and Development BridgeBio Pharma, EMA, FDA, Musculo-skeletal disorder, achondroplasia, clinical trial

BridgeBio Pharma has announced positive feedback from the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) on …

Plus Therapeutics initiates part B of phase 1/2a ReSPECT-LM trial for leptomeningeal metastase

September 6, 2023 Research and Development Oncology, Plus Therapeutics, clinical trial, leptomeningeal metastase

Plus Therapeutics has announced that the first patient has begun treatment in part B of the ReSPECT-LM phase 1/2a dose …

ACM Biolabs shares positive results from phase 1 SARS-CoV-2 booster vaccine trial

September 5, 2023 Research and Development ACM Biolabs, COVID-19, Immunology, SARS-CoV-2, Vaccine, clinical trial

ACM Biolabs has announced positive topline results from its phase 1 trial of ACM-001, an adjuvanted booster vaccine for SARS-CoV-2, …

Genentech shares phase 3 results for ALK-positive early-stage lung cancer treatment

September 1, 2023 Research and Development Genentech, NSCLC, Oncology, clinical trials, lung cancer

Roche’s Genentech has announced that the phase 3 ALINA trial assessing Alecensa, compared with platinum-based chemotherapy for the treatment of …

Twist Bioscience and Ono Pharmaceutical enter agreement for discovery of novel antibodies

August 31, 2023 Research and Development Immunology, Ono Pharmaceutical, Twist Bioscience, antibodies, autoimmune diseases

Twist Bioscience has announced that it has entered a drug discovery agreement with Ono Pharmaceutical for the discovery and development …

Merck’s Keytruda approved by EC for gastric cancer

August 30, 2023 Research and Development EC, Merck, Oncology, gastric cancer, keytruda

Merck (known as MSD outside of the US and Canada) has announced the approval of its gastric cancer treatment, Keytruda, …

FDA approves BMS’s Reblozyl for treatment of anaemia in adults with lower-risk MDS

August 30, 2023 Research and Development FDA, Haematology, Reblozyl, anaemia, bristol myers squibb, myelodysplastic syndromes

Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the …

Latest content